Evidence map›Paper›PMID 37430101›Full record

ArticleScientific reports2023

Spheresomes are the main extracellular vesicles in low-grade gliomas.

Marta Baselga, Pablo Iruzubieta, Tomás Castiella, Marta Monzón, Eva Monleón, Carmen Berga, Alberto J Schuhmacher, Concepción Junquera

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marta BaselgaInstitute for Health Research Aragon (IIS Aragón), 50009, Zaragoza, Spain.
Pablo IruzubietaDepartment of Human Anatomy and Histology, University of Zaragoza, 50009, Zaragoza, Spain.
Tomás CastiellaDepartment of Pathological Anatomy, Legal Medicine, and Toxicology, University of Zaragoza, 50009, Zaragoza, Spain.
Marta MonzónInstitute for Health Research Aragon (IIS Aragón), 50009, Zaragoza, Spain.
Eva MonleónInstitute for Health Research Aragon (IIS Aragón), 50009, Zaragoza, Spain. emonleon@unizar.es.
Carmen BergaDepartment of Human Anatomy and Histology, University of Zaragoza, 50009, Zaragoza, Spain.
Alberto J SchuhmacherInstitute for Health Research Aragon (IIS Aragón), 50009, Zaragoza, Spain.
Concepción JunqueraInstitute for Health Research Aragon (IIS Aragón), 50009, Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer progression and its impact on treatment response and prognosis is deeply regulated by tumour microenvironment (TME). Cancer cells are in constant communication and modulate TME through several mechanisms, including transfer of tumour-promoting cargos through extracellular vesicles (EVs) or oncogenic signal detection by primary cilia. Spheresomes are a specific EV that arise from rough endoplasmic reticulum-Golgi vesicles. They accumulate beneath cell membrane and are released to the extracellular medium through multivesicular spheres. This study describes spheresomes in low-grade gliomas using electron microscopy. We found that spheresomes are more frequent than exosomes in these tumours and can cross the blood-brain barrier. Moreover, the distinct biogenesis processes of these EVs result in unique cargo profiles, suggesting different functional roles. We also identified primary cilia in these tumours. These findings collectively contribute to our understanding of glioma progression and metastasis.

Indexed as

ExosomesExtracellular VesiclesGliomaBlood-Brain BarrierCell MembraneHumansTumor Microenvironment

Identifiers

PMID37430101
PMCPMC10333278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.